CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Cash flows from operating activities
Net income (loss)	$ 5,070	$ (12,024)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization	449	253
Stock-based compensation expense	3,917	1,022
Bad debt expense, net of recoveries	1,378	1,177
Noncash lease costs	0	230
Noncash amortization of debt discount	506	0
Noncash interest expense associated with convertible debt	243	1,370
Noncash change in fair value of derivatives	(36,823)	0
Other	46	44
Changes in operating assets and liabilities:
Accounts receivable	(1,718)	(1,802)
Prepaid expenses and other current assets	(580)	(283)
Accounts payable	424	(397)
Accrued expenses and other current liabilities	(983)	3,172
Deferred revenue	(17)	390
Net cash used in operating activities	(28,088)	(6,848)
Cash flows from investing activities
Additions of property, equipment, and software	(2,470)	(87)
Net cash used in investing activities	(2,470)	(87)
Cash flows from financing activities
Proceeds from exercise of stock options	158	334
Proceeds from convertible promissory notes	29,374	31,470
Proceeds from business combination placed in escrow and restricted	39,032	0
Trust proceeds received from recapitalization at closing	582	0
Repurchase of common stock and settlement of forward purchase agreements	(31,303)	0
Transaction costs associated with recapitalization	(10,761)	(855)
Payments on related party payables	(17)	(253)
Net cash provided by financing activities	27,065	30,696
Net (decrease) increase in cash, cash equivalents, and restricted cash	(3,493)	23,761
Cash, cash equivalents, and restricted cash, beginning of year	28,695	4,934
Cash, cash equivalents, and restricted cash, end of year	25,202	28,695
Supplemental disclosure of non-cash financing activities
Transaction costs associated with recapitalization in accounts payable and accrued expenses	0	1,985
Stockholder contribution for debt issuance costs	924	0
Repurchase of common stock in other accrued expenses	360	0
Conversion of promissory notes into common stock	33,024	0
Issuance of forward share purchase agreements	14,170	0
Issuance of private warrants	3,916	0
Issuance of sponsor shares subject to earnout conditions	6,867	0
Issuance of stockholder earn-out rights	$ 26,131	$ 0